Thrombocytopenia in neonates: causes and outcomes

[1]  R. Christensen,et al.  Thrombocytosis and thrombocytopenia in the NICU: incidence, mechanisms and treatments , 2012, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.

[2]  H. Sallmon,et al.  Clinical and research issues in neonatal anemia and thrombocytopenia , 2012, Current opinion in pediatrics.

[3]  J. Khoury,et al.  Characterizing maternal glycemic control: a more informative approach using semiparametric regression , 2012, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.

[4]  I. Roberts,et al.  How I manage neonatal thrombocytopenia , 2012, British journal of haematology.

[5]  A. Kent,et al.  Mortality and Adverse Neurologic Outcomes Are Greater in Preterm Male Infants , 2012, Pediatrics.

[6]  S. Holzhauer,et al.  Diagnosis and management of neonatal thrombocytopenia. , 2011, Seminars in fetal & neonatal medicine.

[7]  Jodi Beachy.  Neonatal Alloimmune Thrombocytopenia: A Case Study , 2011, Neonatal Network.

[8]  R. Christensen.  Platelet Transfusion in the Neonatal Intensive Care Unit: Benefits, Risks, Alternatives , 2011, Neonatology.

[9]  F. Walther,et al.  Thrombocytopenia in neonates and the risk of intraventricular hemorrhage: a retrospective cohort study , 2011, BMC pediatrics.

[10]  P. Clarke,et al.  Prospective, Observational Study of Outcomes in Neonates With Severe Thrombocytopenia , 2009, Pediatrics.

[11]  H. Sallmon,et al.  New insights into the mechanisms of nonimmune thrombocytopenia in neonates. , 2009, Seminars in perinatology.

[12]  M. Kroh,et al.  Analysis of outcome in 298 extremely low-birth-weight infants with patent ductus arteriosus. , 2009, Journal of pediatric surgery.

[13]  Y. Ramesh Bhat,et al.  Neonatal thrombocytopenia associated with maternal pregnancy induced hypertension , 2008, Indian journal of pediatrics.

[14]  M. Saxonhouse,et al.  Neonatal thrombocytopenia: what we do and don't know. , 2008, Early Human Development.

[15]  K. Sekar,et al.  Treatment of patent ductus arteriosus: indomethacin or ibuprofen? , 2008, Journal of Perinatology.

[16]  R. Christensen,et al.  Do platelet transfusions in the NICU adversely affect survival? Analysis of 1600 thrombocytopenic neonates in a multihospital healthcare system , 2007, Journal of Perinatology.

[17]  S. Ogawa,et al.  In Vivo Effects of Notch Signaling Inhibitor on Tumor Growth and Its Mechanism of Action. , 2006 .

[18]  A. Casbard,et al.  A multi-centre prospective observational study of platelet transfusion practice in neonates with severe thrombocytopenia. , 2006 .

[19]  T. Kiehn,et al.  Thrombocytopenia among extremely low birth weight neonates: data from a multihospital healthcare system , 2006, Journal of Perinatology.

[20]  I. Roberts,et al.  Neonatal thrombocytopenia. , 2005, Early human development.

[21]  I. Roberts,et al.  Neonatal thrombocytopenia: causes and management , 2003, Archives of disease in childhood. Fetal and neonatal edition.

[22]  D. Cooney,et al.  Patent ductus arteriosus in micropreemies and full-term infants: the relative merits of surgical ligation versus indomethacin treatment. , 2003, Journal of pediatric surgery.

[23]  L. Rimsza,et al.  Mechanisms underlying thrombocytopenia in the neonatal intensive care unit , 2002, Acta paediatrica (Oslo, Norway : 1992). Supplement.

[24]  E. Letsky,et al.  Platelet transfusion in the management of severe thrombocytopenia in neonatal intensive care unit patients , 2002, Transfusion medicine.

[25]  D. Theriaque,et al.  Epidemiologic and Outcome Studies of Patients Who Received Platelet Transfusions in the Neonatal Intensive Care Unit , 2001, Journal of Perinatology.

[26]  D. Theriaque,et al.  Platelet transfusions in the neonatal intensive care unit:factors predicting which patients will require multiple transfusions , 2001, Transfusion.

[27]  M. Uhrynowska,et al.  Neonatal and maternal thrombocytopenia: incidence and immune background , 2000, European journal of haematology.

[28]  I. Roberts,et al.  Haematological abnormalities in the growth-restricted infant , 1999 .

[29]  I. Durand-zaleski,et al.  Frequency of immune thrombocytopenia in newborns: a prospective study. Immune Thrombocytopenia Working Group. , 1997, Blood.

[30]  I. Roberts,et al.  Circulating Megakaryocytes and Their Progenitors in Early Thrombocytopenia in Preterm Neonates , 1996, Pediatric Research.

[31]  A. Homans.  Thrombocytopenia in the neonate. , 1996, Pediatric clinics of North America.

[32]  N. Olgun,et al.  Assessment of clinical impact and predisposing factors for neonatal thrombocytopenia , 1994, Indian journal of pediatrics.

[33]  S. Jain.  Ibuprofen-induced thrombocytopenia. , 1994, The British journal of clinical practice.

[34]  T. Gomella.  Neonatology: Management, Procedures, On-Call Problems, Diseases, Drugs , 1992 .

[35]  J. Kelton,et al.  Frequency and mechanism of neonatal thrombocytopenia. , 1986, The Journal of pediatrics.

[36]  L Neumann,et al.  Thrombocytopenia in the high-risk infant. , 1980, The Journal of pediatrics.